A Randomized Controlled Trial Of Buzhongyiqi Herbal Soup In The Treatment Of Allergic Rhinitis

Objective: The clinical efficacy of Buzhong Yiqi decoction combined with montelukast sodium in the treatment of allergic rhinitis of lung-qi deficiency type was studied in a randomized controlled clinical trial to explore the therapeutic advantage of this combined method in the treatment of allergic rhinitis of lung-qi deficiency type.To provide a certain basis for the treatment of allergic rhinitis by traditional Chinese medicine and western medicine.Method: From January 2018 to December 2018,60 cases of allergic rhinitis of lung-spleen deficiency type diagnosed by our department of otorhinolaryngology from January 2018 to December 2018 were collected by clinical randomized controlled study.The patients were treated with 4 weeks as a course of treatment.Symptoms and signs were evaluated for 2 weeks and 4 weeks after treatment,and statistical analysis was performed.Results:During the trial,5 cases in the control group and 4 cases in the test group were lost.Finally,25 cases in the control group and 26 cases in the treatment group were included in the study.(1)After 2 weeks of treatment,the symptoms of runny nose and nasal congestion in the experimental group were significantly better than those in the control group(P < 0.05).However,there was no significant difference in nasal itching and sneezing symptoms and signs(turbinate hypertrophy)(P > 0.05).(2)After 2 weeks of treatment,the effective rate of the experimental group was higher than that of the control group,and the difference of the total effective rate was 6% >? = 4%,while the confidence interval of 95% of the score decline index of the experimental group was[21.55,33.51].The confidence interval of 95% of the score decline index in the control group was [16.91,32.54].The difference between the upper limit was <? =4%and the lower limit of the two groups was>? =4%.(3)After 4 weeks of treatment,the symptoms of nasal itching and nasal congestion in the experimental group were significantly better than those in the control group(P < 0.05).However,there was no significant difference in runny nose and sneezing symptoms and signs(turbinate hypertrophy)(P > 0.05).(4)After 4weeks of treatment,the effective rate of the experimental group was higher than that of the control group,the difference of the total effective rate was 9% >? = 4%,while the 95%confidence interval of the effective rate of the experimental group was[42.84,64.32],and the 95% confidence interval of the effective rate of the control group was [34.05,59.50].The difference between upper and lower limits is more than ?= 4%.